The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Elevance Health Inc shares valued at $1,949,074 were sold by Kaye Mark on Apr 24 ’25. At $424.82 per share, Kaye Mark sold 4,588 shares. The insider’s holdings dropped to 18,977 shares worth approximately $7.08 million following the completion of this transaction.
Also, Kaye Mark purchased 4,588 shares, netting a total of over 1,949,051 in proceeds.
Before that, Penczek Ronald W had sold 443 shares from its account. In a trade valued at $183,903, the CAO & Controller traded Elevance Health Inc shares for $415.13 each. Upon closing the transaction, the insider’s holdings decreased to 443 shares, worth approximately $0.69 million.
As published in a research note from Robert W. Baird on April 15, 2025, Elevance Health Inc [ELV] has been rated down from an Outperform to a Neutral and the price target has been revised to $529. Analysts at Argus upgraded the stock from ‘”a Hold”‘ to ‘”a Buy”‘ outlook in a report released in mid March. As of January 22, 2025, Stephens has decreased its “an Overweight” rating to a “an Equal-weight” for ELV. Earlier on October 18, 2024, Argus downgraded its rating. Their new recommendation was “a Hold” for ELV stock which previously was a “a Buy”.
Analyzing ELV Stock Performance
On last trading session,, Elevance Health Inc [NYSE: ELV] plunged -0.18% to $373.18. The stock’s lowest price that day was $371.37, but it reached a high of $379.28 in the same session. During the last five days, there has been a drop of approximately -0.73%. Over the course of the year, Elevance Health Inc shares have dropped approximately -31.11%. Shares of the company reached a 52-week high of $458.75 on 04/08/25 and a 52-week low of $357.45 on 05/15/25.
Support And Resistance Levels for Elevance Health Inc (ELV)
According to the 24-hour chart, there is a support level at 369.65, which, if violated, would cause prices to drop to 366.11. In the upper region, resistance lies at 378.00. The next price resistance is at 382.81. RSI (Relative Strength Index) is 40.70 on the 14-day chart, showing neutral technical sentiment.
Is Elevance Health Inc subject to short interest?
Stocks of Elevance Health Inc saw a sharp steep in short interest on 2025-06-13 dropping by -0.1 million shares to 2.5 million. Data from Yahoo Finance shows that the short interest on 2025-05-15 was 2.61 million shares. A decline of -4.13% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 1.29 of the overall float, the days-to-cover ratio (short ratio) decline to 1.29.
Which companies own the most shares of Elevance Health Inc (ELV)?
In terms of Elevance Health Inc share price expectations, FactSet research, analysts set an average price target of 482.5 in the next 12 months, up nearly 29.06% from the previous closing price of $373.86. Analysts anticipate Elevance Health Inc stock to reach 500 by 2025, with the lowest price target being 465. In spite of this, 12 analysts ranked Elevance Health Inc stock as Buy at the end of 2025. On July 18, 2024, BofA Securities assigned a price target of “a Neutral” to the stock and downgraded coverage with a $530.
